Colorado BioScience Association
Colorado BioScience Association

Rocky Mountain Life Science Investor & Partnering Conference Announces Thirty Regional Companies for 2013 Presentation Lineup

The 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 18-19 at The Ritz-Carlton, Denver.

Denver, CO, August 12, 2013 --( Thirty companies from Arizona, Colorado, Montana and Utah have been chosen to present at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 18-19, at The Ritz-Carlton in Denver, Colorado. The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA), on behalf of the RMLIPC Selection Committee, who says the presenting companies were selected from more than 60 applicants by a committee of investors and industry experts.

“Our investor and partnering conference, held every other year, is one of the most important events we orchestrate at CBSA. It has been a rewarding experience for our team to see the conference grow and develop since our first session in 2009,” Giles said. “We owe our success to the support of our founding partner, Johnson & Johnson Development Corporation, who has contributed significantly and been instrumental to the growth of this conference. We currently have confirmation from just shy of 50 investors from across the country to participate in the conference.”

2013 Rocky Mountain Life Science Investor and Partnering Conference Presenting Companies:

AmideBio, LLC - Boulder, CO -

Biodesix - Boulder, CO -

BioFusionary - Wheat Ridge, CO -

Boulder Diagnostics - Boulder, CO -

Convoy Therapeutics - Oro Valley, AZ -

DiscGenics - Salt Lake City, UT -

EndoShape - Boulder, CO -

ENDURX Pharmaceuticals, Inc. - Oro Valley, AZ -

FitBionic - Boulder, CO -

Lazarus Medical Technologies - Salt Lake City, UT -

Lineagen - Salt Lake City, UT -

MBio Diagnostics - Boulder, CO -

MSDx - Tucson, AZ -

Nasseo, Inc. - Peoria, AZ -

Neuro Assessment Systems - Littleton, CO -

Prima-Temp, Inc. - Boulder, CO -

Regenesis Biomedical - Scottsdale, AZ -

Renaptys Vaccines, LLC - Aurora, CO -

Rocky Mountain Biologicals - Missoula, MT -

Sharklet Technologies, Inc. - Aurora, CO -

Sinopsys Surgical - Boulder, CO -

Surefire Medical - Westminster, CO -

SuviCa - Boulder, CO -

Transverse Medical - Evergreen, CO -

Ventria Bioscience - Fort Collins, CO -

VetDC Inc. - Fort Collins, CO -

Vivaldi Biosciences - Fort Collins, CO -

Wasatch - Salt Lake City, UT -

Xalud Therapeutics, Inc. Boulder, CO -

Xenograft Corporation - Missoula, MT -

About the Rocky Mountain Life Science Investor & Partnering Conference

The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch will be a presentation from Johnson & Johnson Development Corporation executive leadership. For more information and registration details, visit

On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.

About Colorado BioScience Association

The CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit

CBSA also is found on these social media sites:

LinkedIn Group:
Facebook Fan Page:
News Feed:
YouTube Channel:


Mae Desaire, Director of Marketing, Colorado BioScience Association - – 720-382-5918,

Maggie Chamberlin Holben, APR, Absolutely PR – – 303-984-9801,
Colorado BioScience Association
Maggie Holben